中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2012年
5期
956-957
,共2页
王卫军%张近波%方钱%李剑锋%金鹏飞%李智涛%侯建毅
王衛軍%張近波%方錢%李劍鋒%金鵬飛%李智濤%侯建毅
왕위군%장근파%방전%리검봉%금붕비%리지도%후건의
重症急性胰腺炎%内皮素%参麦注射液
重癥急性胰腺炎%內皮素%參麥註射液
중증급성이선염%내피소%삼맥주사액
Severe acute pancreatitis%Endothelin%Shenmai injection
目的 观察重症急性胰腺炎(SAP)患者血浆内皮素(ET)水平的变化特点及参麦对其影响.方法 按照平行对照设计原理,将所有60名患者分为常规治疗组(A组)和常规治疗+参麦治疗组(B组).对两组患者的相关临床资料及ET水平进行比较.结果 与B组患者比较,A组患者第2天、第4天ET水平均明显升高[(80.36±11.05)比(98.18±11.83)、(93.63±8.59)比(107.53±9.26)](P均<0.05);与B组患者比较,A组患者第7天ET水平明显升高(76.25±10.81比93.17±12.42)(P<0.01);与B组患者比较,A组患者治疗前ET水平两组差异无统计学意义(P>0.05);与B组患者比较,A组患者年龄、性别、APACHEⅡ评分等两组差异无统计学意义(P均>0.05).结论 参麦注射液治疗SAP可有效降低患者血浆中的ET含量,通过改善SAP患者的微循环而起到较好的治疗作用.
目的 觀察重癥急性胰腺炎(SAP)患者血漿內皮素(ET)水平的變化特點及參麥對其影響.方法 按照平行對照設計原理,將所有60名患者分為常規治療組(A組)和常規治療+參麥治療組(B組).對兩組患者的相關臨床資料及ET水平進行比較.結果 與B組患者比較,A組患者第2天、第4天ET水平均明顯升高[(80.36±11.05)比(98.18±11.83)、(93.63±8.59)比(107.53±9.26)](P均<0.05);與B組患者比較,A組患者第7天ET水平明顯升高(76.25±10.81比93.17±12.42)(P<0.01);與B組患者比較,A組患者治療前ET水平兩組差異無統計學意義(P>0.05);與B組患者比較,A組患者年齡、性彆、APACHEⅡ評分等兩組差異無統計學意義(P均>0.05).結論 參麥註射液治療SAP可有效降低患者血漿中的ET含量,通過改善SAP患者的微循環而起到較好的治療作用.
목적 관찰중증급성이선염(SAP)환자혈장내피소(ET)수평적변화특점급삼맥대기영향.방법 안조평행대조설계원리,장소유60명환자분위상규치료조(A조)화상규치료+삼맥치료조(B조).대량조환자적상관림상자료급ET수평진행비교.결과 여B조환자비교,A조환자제2천、제4천ET수평균명현승고[(80.36±11.05)비(98.18±11.83)、(93.63±8.59)비(107.53±9.26)](P균<0.05);여B조환자비교,A조환자제7천ET수평명현승고(76.25±10.81비93.17±12.42)(P<0.01);여B조환자비교,A조환자치료전ET수평량조차이무통계학의의(P>0.05);여B조환자비교,A조환자년령、성별、APACHEⅡ평분등량조차이무통계학의의(P균>0.05).결론 삼맥주사액치료SAP가유효강저환자혈장중적ET함량,통과개선SAP환자적미순배이기도교호적치료작용.
Objective To explore the changes of plasma endothelin(ET) as well as the effects of Shenmai in patients with severe acute pancreatitis (SAP).Methods Sixty patients with SAP were collected,and divided into routine treatment group (group A) and Shenmai treatment group (group B).The clinical data and ET levels were analyzed.Results The levels of ET were significantly higher in group A than those in group B at the day 2 and 4 [ ( 80.36 ± 11.05 ) vs (98.18 ± 11.83 ),and (93.63 ± 8.59) vs ( 107.53 ± 9.26) ] ( both P < 0.05 ).The levels of ET were significantly higher in group A than those in group B at the day 7 (76.25 ± 10.81 vs 93.17 ± 12.42,P <0.01 ).There was no significant difference between group A and group B in age,gender,andAPACHE Ⅱ score(all P>0.05).Conclusion Shenmai injection can effectively reduce the plasma levels of ET in SAP patients,and exert its therapeutic effect through improving microcirculation of SAP patients.